Pulmuone Corporate
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Pulmuone Corporate makes and distributes everyday food products, including fresh foods and dairy-style items, for consumers in South Korea and internationally.
Its products reach end consumers through domestic food manufacturing and distribution, food-service channels, and overseas operations in the United States, China, and Japan. Listed on KOSPI, Korea's main stock exchange, the company operates as a holding company, a parent entity that earns royalties and dividends from its subsidiaries, with domestic food manufacturing and distribution forming the largest share of consolidated revenue.
Summary is AI-generated and may contain errors · figures from DART filings
Pulmuone Corporate is structured as a formal holding company under Korean fair-trade law, sitting above subsidiaries that handle food manufacturing, food services, health-care products, and overseas operations.
Pulmuone Corporate in five facts
What does Pulmuone Corporate do?
Pulmuone Corporate makes and distributes everyday food products, including fresh foods and dairy-style items, for consumers in South Korea and internationally.
Where is Pulmuone Corporate listed and in which sector?
Pulmuone Corporate (Korean name: 풀무원) trades under KRX code 017810 on KOSPI, the main board of the Korea Exchange. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Pulmuone Corporate?
Its market capitalisation was US$243.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Pulmuone Corporate's latest annual revenue and operating profit?
For fiscal year 2025, Pulmuone Corporate reported revenue of US$2.6B, operating profit of US$70.3M and net income of US$11.4M, per its annual report on DART (data retrieved from DART on 2026-09-08). Revenue was up 5.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-08
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- DisclosureSep 22
- Report on large shareholdings (5% rule) (standard)Sep 11
- Material event report (rights offering)
Pulmuone Corporate disclosed convertible bonds to raise US$27.7M, about 11.9% of its market value.
Capital raise · Jul 29 - Cash/in-kind dividend decision (subsidiary)Dividend · Mar 11
- Cash/in-kind dividend decision (subsidiary) (subsidiary)Dividend · Mar 11
- Cash/in-kind dividend decision
Pulmuone Corporate declared a cash dividend of US$0.07 per share.
Dividend · Feb 10 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)
Pulmuone Corporate updated its previously filed a subsidiary's consolidated results for FY2025: revenue of US$636M (+11.57% year on year), operating profit of US$23.2M (+31.34% year on year) and net income of US$4.38M (from a loss a year earlier).
Earnings · Feb 3 - Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)
Pulmuone Corporate reported a subsidiary's separate results for FY2025: revenue of US$63.7M (+0.05% year on year), operating profit of US$1.65M (−63.82% year on year) and net income of US$2.35M (−53.84% year on year).
Earnings · Feb 3 - Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)
Pulmuone Corporate reported a subsidiary's consolidated results for FY2025: revenue of US$636M (+11.57% year on year), operating profit of US$23.2M (+31.34% year on year) and net income of US$4.38M (from a loss a year earlier).
Earnings · Feb 3 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)Earnings · Feb 2